Navigation Links
UGA researchers explore function of cancer-causing gene
Date:3/26/2014

Athens, Ga. Developmental biologists at the University of Georgia are discovering new roles for a specific gene known as Max's Giant Associated protein, or MGA. A little studied protein, MGA appears to control a number of developmental processes, and also may be connected to cancer development.

The researchers detail their findings in a paper published recently in the journal Developmental Cell.

"The same genes that are involved in building a person during embryonic development can mutate and cause cancer later in life," said Scott Dougan the study's principal investigator and Georgia Cancer Coalition Distinguished Cancer Scientist in UGA's Department of Cellular Biology. "No one has done a systematic study of MGA, but now that some studies connect it to cancer, there is tremendous interest."

The most common cancer associated with MGA is chronic lymphocytic leukemia, a blood and bone marrow disease in which the body produces too many white blood cells. Preliminary tests suggest that this cancer might develop when MGA does not successfully control the activities of another protein known as MYC, which contributes to tumor growth.

Dougan and his team of researchers used their own methods to change the levels of MGA in the embryos of zebrafish to see if they could discover any other roles for MGA.

They found that MGA also helps control expression of the Bone Morphogenetic Proteins, or BMP, which, as the name implies, are responsible for bone development in the embryo. In adults, however, changes in BMP activity can result in tumor development, and MGA may be part of this detrimental transformation.

"Scientists are only beginning to understand the roles this MGA protein plays, but our tests show that MGA may control many more processes than first imagined," said Dougan, who is also a member of UGA's Developmental Biology Alliance. "MGA may be involved in a number of other cancers, but we need to do more research before we're sure."

In the coming months, Dougan and his research team plan to further examine the roles of MGA to determine when it controls MYC, when it controls BMP and how it is involved in tumor formation.

"This is basic science, and we need investigations like these to understand the fundamentals of our biology," Dougan said. "Once we have this understanding, we can begin to develop new therapies to treat diseases in new, more effective ways."


'/>"/>

Contact: Scott Dougan
dougan@uga.edu
706-583-8194
University of Georgia
Source:Eurekalert

Related biology news :

1. Researchers present comprehensive roadmap of blood cells
2. UT Southwestern ob/gyn researchers studying genetic factors in premature births
3. Researchers issue state-of-the-state on genetic-based testing & treatment for breast cancer
4. Miscarriage clues identified in new DNA test according to researchers at Montefiore and Einstein
5. Researchers uncover allergy-cancer connection
6. Vanderbilt diabetes researchers track cells ability to regenerate
7. Researchers devise new, stretchable antenna for wearable health monitoring
8. Researchers find high acceptability of 3-colored raspberry jelly
9. Motion and muscles dont always work in lockstep, researchers find in surprising new study
10. New bilateral pilot opportunity will fund collaborations between US and UK bioscience researchers
11. Bucking conventional wisdom, researchers find black sea bass tougher than expected
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... 2016 The rising popularity of mobility ... is stoking significant interest in keyless access systems. ... low energy (BLE), biometrics and near-field communication (NFC) ... of wireless technologies in the automotive industry. This ... access systems opens the market to specialist companies ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... CLARA, Calif. , Jan. 24, 2017  Frost & Sullivan ... of the Fonar Corporation, will receive special recognition at the ... taking place March 19 to 21, 2017 at the Loews Coronado ... To register and download the event agenda for Medical ... www.frost.com/medtech ...
(Date:1/24/2017)... Pa. , Jan. 24, 2017   Bracket ... provider, today announced the addition of Jennifer Peters ... Senior Vice President and General Manager for the Scientific ... responsible for Bracket,s work in Rater Training, Quality Assurance, ... Bracket with a strong skillset and demonstrated record building ...
(Date:1/24/2017)... MONTREAL , Jan. 24, 2017 /PRNewswire/ - BioAmber Inc. ... demand, the underwriters have agreed to increase the size of ... stock of the Company, together with warrants to purchase 1,842,106 ... price of US$5.50 per share of common stock (the "Exercise ... share and associated warrant (the "Public Price"). The warrants have ...
(Date:1/24/2017)... , ... January 24, 2017 , ... ... label-free graphene biosensor assays for fragment-based screening, will showcase its proprietary ... Society for Laboratory Automation and Screening (SLAS) conference in Washington, D.C. from Feb. ...
Breaking Biology Technology: